PIPPIN ripped 60% to $0.51 after breaking out of a multi-week downtrend. The spike was amplified by a short squeeze and a 62% ...
Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical ...
・Spyre Therapeutics (SYRE) has strong technical momentum and is trading at a new 52 week high. ・SYRE maintains a 100% “Buy” opinion from Barchart. ・Shares are up more than 50% in the past month. ・High ...
This latest round of short squeeze hype is picking up, with plant-based meat company Beyond Meat leading the charge. Beyond Meat's roughly 1,600% rally had nothing to do with a short squeeze and ...